The National Institutes of Health (NIH) is offering funding opportunities through a Notice of Funding Opportunity (NOFO) aimed at advancing translational research on Alzheimer's Disease (AD) and related dementias. The initiative, titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD-Related Dementias (T32 Clinical Trial Not Allowed)," is particularly focused on developing a diverse workforce of researchers capable of engaging in interdisciplinary team science. The program encourages proposals for training programs at both predoctoral and postdoctoral levels, emphasizing hands-on experience, collaboration across various scientific disciplines, and promoting diversity and inclusion. Key components of the grant include support for stipends, tuition, training-related expenses, and the requirement for applicants to submit via specific electronic submission systems. Applications are due by specified dates, with eligibility extended to diverse institutions, including minority-serving organizations. The overarching goal is to improve understanding and treatment of aging-related health issues while ensuring a commitment to scientific integrity and rigorous research training. The NIH intends to award an estimated 3-5 grants annually over the next three years, with a total budget of $2.7 million, contingent on appropriations and quality applications.